Biopharmaceutics
Research from Antibioticos S.A. yields new data on biopharmaceutics
Published in Medical Device Business Week, February 28th, 2007
A new study, "Cefdinir: A comparative study of anhydrous vs. monohydrate form. Microstructure and tabletting behaviour," is now available. According to recent research published in the European Journal of Pharmaceutics and Biopharmaceutics, "Anhydrous cefdinir (AC) vs. monohydrated cefdinir (MHC) was compared in order to be used as antimicrobial in therapeutics. Different techniques have been used to characterize physically AC and MHC, and also a complete microstructural analysis of raw materials was carried out."
"Cefdinir and Maltodextrin QDM 500 (3:2) formulations were compressed in order to obtain tablets with typical dose of Cefdinir, i.e. 300 mg....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Business Week
More Articles from Medical Device Business Week
- Anemia Genetics
Reports outline anemia genetics research from Shionogi and Co., Ltd. - Angiogenesis
Recent findings from Meiji Dairies Corporation highlight research in angiogenesis - Awards
Tecan wins Salzburg Chamber of Commerce awards for best company, overall for innovation - Awards
Toshiba American Medical Systems named Best in KLAS in CT and MR for 2006 - Blood Clots
sanofi-aventis lauds new standards for prophylaxis of blood clots in surgical patients - Breast Cancer Therapy
Data on breast cancer therapy discussed by researchers at GlaxoSmithKline, Department of Oncology - More from this issue of Medical Device Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
